Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

This a repost of mine from yahoo site

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
vorlon1966 Member Profile
Member Level 
Followed By 29
Posts 577
Boards Moderated 0
Alias Born 12/05/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2014 6:00:08 AM
Provectus’ Intralesional PV-10 Clinical Data to Be Presented to the 2014 International Congress of the Society for Melanoma... "Business Wire" - 10/16/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 6:04:52 AM
Provectus’ Intralesional PV-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting "Business Wire" - 10/15/2014 6:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/15/2014 5:59:30 AM
INC Research Signs Agreement to Perform FDA Due Diligence Audit of Regulatory Documents for Provectus Biopharmaceuticals "Business Wire" - 10/14/2014 9:53:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/14/2014 9:39:06 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/8/2014 6:00:54 AM
Provectus’ Intralesional PV-10 Clinical Data to Be Presented to the Eurasian Federation of Oncology "Business Wire" - 10/8/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/7/2014 6:01:59 AM
Provectus’ Intralesional PV-10 to Be Presented at the 2014 Beijing International Melanoma Congress "Business Wire" - 10/7/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2014 6:15:15 AM
Provectus Biopharmaceuticals Data Presented At ESMO 2014 Congress Show Ablative, Bystander Effects Of PV-10 "Business Wire" - 9/29/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 6:02:58 AM
Provectus Biopharmaceuticals’ PV-10 Clinical Data on Melanoma Now Available for European Society for Medical Oncology 2014 ... "Business Wire" - 9/24/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/23/2014 6:04:20 AM
Provectus’ Intralesional Pv-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting "Business Wire" - 9/23/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2014 6:08:53 AM
Provectus Biopharmaceuticals Appoints Christopher Kaplan to Its Strategic Advisory Board "Business Wire" - 9/22/2014 6:00:00 AM
プロヴェクタスが国薬-中国医薬工業研究総院および国薬一心制薬有限公司と了解覚書を交わす "Business Wire" - 8/21/2014 5:46:00 AM
Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, & Sinopharm A-TH... "Business Wire" - 8/18/2014 9:19:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/18/2014 8:30:16 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2014 6:03:48 AM
Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly Conference Calls on Thursday, August 7, 2014 "Business Wire" - 8/6/2014 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/31/2014 6:16:47 PM
vorlon1966 Member Level  Saturday, 12/28/13 12:08:00 PM
Re: buccaneer1961 post# 919
Post # of 6740 
This a repost of mine from yahoo site answering questions and comments.

They never failed
They shut down photogen to start pvct when they figured out they had a better product
They did get paid a few years a bunch.... They also are getting a product to market for around $130mm instead of $1.5 billion and in less time than normal.... We benefited from that because there are no partners to share in the end game... Probably would not be an end game otherwise....they would have taken over and you might have gotten a few bucks increase instead of the big payoff that's coming
They did not go for pIII right away when they realized they could invent a new synthesis for rb that can be approved internationally for oncology....99% purity
Patent awarded this year ....you have to go into pIII with the drug that gets approved...so they waited for the patent
PIII? No mention in 8k..... What was mentioned was btd and aa
Deliberate omission? Judge for yourself.
Large production runs done for Nda and ready to ship...hmmmmm.
Second Pfizer guy on advisory board with Chinese pharma experience
They have been working on a Chinese regional deal waiting on FDA clarity....hmmmmm
First Pfizer board member is an acquisition specialist.....hmmmmm
They changed their name and state of incorporation......around same time as FDA meeting.....hmmmmm
Pfizer losing patents on Lipitor and Viagra .....hmmmmm

You guys not getting this......???? hmmmmmm...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist